David Katz Bristol Myers Squibb CO Transaction History

Matrix Asset Advisors Inc

$1.02 Billion
Q4 2025

A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 3,929 shares of BMY stock, worth $183,916. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,929

Holding current value

$183,916

% of portfolio

0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 16, 2026	BUY	$42.6 - $49.08 $167,375 - $192,835	3,929 New	3,929 $183,000
Q2 2025 Jul 25, 2025	BUY	$44.12 - $59.6 $28,104 - $37,965	637 Added 15.57%	4,729 $218,000
Q1 2025 Apr 22, 2025	SELL	$53.9 - $63.11 $73,142 - $85,640	-1,357 Reduced 24.9%	4,092 $249,000
Q4 2024 Jan 22, 2025	SELL	$51.92 - $59.94 $8,826 - $10,189	-170 Reduced 3.03%	5,449 $308,000
Q3 2024 Oct 10, 2024	BUY	$39.66 - $51.75 $594 - $776	15 Added 0.27%	5,619 $290,000

Q2 2024 Jul 15, 2024	BUY	$40.25 - $52.99 $2,213 - $2,914	55 Added 0.99%	5,604 $232,000
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $5,229 - $5,929	109 Added 2.0%	5,549 $300,000
Q2 2023 Jul 18, 2023	SELL	$63.71 - $70.74 $1,274 - $1,414	-20 Reduced 0.37%	5,440 $347,000
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $78,194 - $88,690	-1,190 Reduced 17.89%	5,460 $378,000
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $4 - $2,689	-35 Reduced 0.52%	6,650 $473,000
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $36,237 - $39,910	-499 Reduced 6.95%	6,685 $515,000
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $61,295 - $73,498	-997 Reduced 12.19%	7,184 $525,000
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $482 - $562	-9 Reduced 0.11%	8,181 $510,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $355 - $415	6 Added 0.07%	8,190 $485,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1,362 - $1,483	22 Added 0.27%	8,184 $547,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $148,171 - $166,649	-2,497 Reduced 23.43%	8,162 $515,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $866 - $981	15 Added 0.14%	10,659 $661,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $574 - $636	10 Added 0.09%	10,644 $642,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $109 - $128	-2 Reduced 0.02%	10,634 $625,000
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $49,369 - $71,745	-1,064 Reduced 9.09%	10,636 $593,000
Q4 2019 Feb 11, 2020	SELL	$49.21 - $64.19 $29,772 - $38,834	-605 Reduced 4.92%	11,700 $751,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $223 - $246	5 Added 0.04%	12,305 $558,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $132,382 - $157,849	-2,934 Reduced 19.26%	12,300 $587,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $97,763 - $126,776	-2,005 Reduced 11.63%	15,234 $792,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $35,118 - $43,771	-695 Reduced 3.88%	17,239 $954,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $1,797 - $2,069	-30 Reduced 0.17%	17,934 $1.13 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $599 - $653	-10 Reduced 0.06%	17,964 $1.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $992,704 - $1.15 Million	17,974	17,974 $1.15 Million

Others Institutions Holding BMY

# of Institutions

2,709

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track David Katz's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.

Account